BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6610619)

  • 1. Monoclonal antibody studies in B-cell chronic lymphocytic leukemia and allied disorders.
    Aisenberg AC; Wilkes BM
    Hematol Oncol; 1983; 1(1):13-9. PubMed ID: 6610619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody studies in non-Hodgkin's lymphoma.
    Aisenberg AC; Wilkes BM; Harris NL
    Blood; 1983 Mar; 61(3):469-75. PubMed ID: 6824784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
    Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
    J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.
    Aisenberg AC; Bloch KJ; Wilkes BM
    J Exp Med; 1981 Nov; 154(5):1709-14. PubMed ID: 6975352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--I. Retention of morphology, phenotype and selective cytotoxic properties in long term culture.
    Vyth-Dreese FA; de Vries JE
    Leuk Res; 1984; 8(1):1-14. PubMed ID: 6321859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lymphocytic leukemia B-lymphocytes forming SRBC-rosettes not due to an anti-SRBC activity of monoclonal surface immunoglobulin.
    Herrmann F; Kolecki P; Sieber G; Ludwig WD; Komischke B; Rühl H
    Am J Clin Pathol; 1985 Feb; 83(2):249-53. PubMed ID: 3871584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of immunotyping in chronic lymphocytosis: review of the natural history of the condition in 145 adult patients.
    Tefferi A; Li CY; Phyliky RL
    Mayo Clin Proc; 1988 Aug; 63(8):801-6. PubMed ID: 2456433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predominant lymphocyte in most thymomas and in nonneoplastic thymus from patients with myasthenia gravis is the cortical thymocyte.
    Aisenberg AC; Wilkes B; Harris NL; Frist WH
    Clin Immunol Immunopathol; 1985 Apr; 35(1):130-6. PubMed ID: 3995797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of 3A1 monoclonal antibody in the diagnosis of T-cell acute lymphoblastic leukemia.
    Lopez M; De Rossi G; Bonomo G; Napolitano M; Pasqualetti D; Guglielmi C; Annino L; Pandolfi F
    Diagn Immunol; 1985; 3(1):11-4. PubMed ID: 3873317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoid leukemia and non-Hodgkin's lymphoma type continuum, superimposed to lymphocyte differentiation step continuum. A proposition for a revised W. H. O. lympiioid leukemia-lymphoma categorisation.
    Mathé G
    Biomed Pharmacother; 1985; 39(3):109-14. PubMed ID: 3864494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
    Han T; Ozer H; Minowada J
    Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIg-E- ("null-cell") non-Hodgkin's lymphomas. Multiparametric determination of their B- or T-cell lineage.
    Knowles DM; Dodson L; Burke JS; Wang JM; Bonetti F; Pelicci PG; Flug F; Dalla-Favera R; Wang CY
    Am J Pathol; 1985 Sep; 120(3):356-70. PubMed ID: 2931028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
    Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
    Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markers.
    Bergmann L; Mitrou PS; Cherdron T; Holloway K; Jost J; Timm V; Zerth G
    Scand J Haematol; 1982 Sep; 29(3):224-34. PubMed ID: 6983113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunodiagnosis of chronic lymphatic leukemia and leukemic non-Hodgkin's lymphoma with the monoclonal antibodies BL-Ig-L/1, BL-DR/1 and BL-T2].
    Malberg K; Fischer H; Elendt D; Wutke K; Fiebig H
    Arch Geschwulstforsch; 1984; 54(4):325-32. PubMed ID: 6437368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
    Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
    Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ immunologic characterization of follicular lymphomas.
    Ancelin E; Delsol G; Familiades J; Mason DY; Kuhlein E; Al Saati T; Laurent G; Huguet-Rigal F
    Hematol Oncol; 1984; 2(3):221-37. PubMed ID: 6384007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.